PAPER Lelo de Larrea-Mancera ES, Flores-Medina Y, Seitz AR, Alcalá-Lozano R
SEARCH RESULTS
346620 RESULTS
PAPER Mercado G, Clabout AC, Howland V, Arkin E, Janer AB, Plessers D, Steiner JA, Smith WW, Hannan T, Brundin P, Peelaerts W
Chronic urinary tract infections cause persistent microglial changes in a humanized ɑ-synuclein mouse model.
J Parkinsons Dis. 2024 Nov;14(8):1559-1574. Epub 2024 Dec 27 PubMed.PAPER Aiello EN, Curti B, De Luca G, Trombi M, Maranzano A, Poletti B, Silani V, Ticozzi N, Verde F
Prevalence and correlates of the head turning sign in mild cognitive impairment and dementia due to neurodegenerative, chronic cerebrovascular, and mixed etiologies.
J Alzheimers Dis. 2025 Feb 16;:13872877251318011. Epub 2025 Feb 16 PubMed.PAPER Kroll F, Donnelly J, Özcan GG, Mackay E, Rihel J
Behavioural pharmacology predicts disrupted signalling pathways and candidate therapeutics from zebrafish mutants of Alzheimer's disease risk genes.
Elife. 2025 Feb 17;13 PubMed.PAPER Azizan Z, Bazrgar M, Bazgir N, Moini SH, Ghaseminejad-Kermani S, Safa K, Eshaghian-Dorcheh A, Harirchian MH
Osteopontin in Alzheimer's Disease: A Double-Edged Sword in Neurodegeneration and Neuroprotection-A Systematic Review.
CNS Neurosci Ther. 2025 Feb;31(2):e70269. PubMed.PAPER Puoyan-Majd S, Parnow A, Rashno M, Heidarimoghadam R, Komaki A
Effects of Pretreatment With Coenzyme Q10 (CoQ10) and High-Intensity Interval Training (HIIT) on FNDC5, Irisin, and BDNF Levels, and Amyloid-Beta (Aβ) Plaque Formation in the Hippocampus of Aβ-Induced Alzheimer's Disease Rats.
CNS Neurosci Ther. 2025 Feb;31(2):e70221. PubMed.PAPER Zhu XC, Mizutani Y, Ohdake R, Tatebe H, Maeda T, Shima S, Ueda A, Ito M, Ito S, Tokuda T, Watanabe H
CSF GPNMB in Parkinson's disease: A potential association with age and microglial activation.
J Parkinsons Dis. 2024 Nov;14(8):1533-1542. Epub 2024 Dec 8 PubMed.PAPER Oyovwi MO, Udi OA, Atere AD, Joseph GU, Ogbutor UG
Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy.
Mol Biol Rep. 2025 Feb 17;52(1):240. PubMed.PAPER Santos RX, Lee SH, Lofthouse R, Melis V, Robinson L, Leith M, Dreesen E, Armstrong P, Vorley T, Goatman EA, Hull C, Riedel G, Wischik CM, Harrington CR
Hydromethylthionine sustains truncated tau-dependent inflammation-lowering effects in mouse brain.
FEBS J. 2025 Feb 17; Epub 2025 Feb 17 PubMed.PAPER Cerqueni G, Terenzi V, Preziuso A, Serfilippi T, Piccirillo S, Di Vincenzo M, Ambrogini P, Amoroso S, Orciani M, Lariccia V, Magi S
Identification of glutamate-related disease-dependent alterations in subventricular NSCs of the 3xTg Alzheimer's disease model, could they be involved in attempting damage repair?
Cell Tissue Res. 2025 Feb 17; Epub 2025 Feb 17 PubMed.PAPER Zhang KX, Zhang JW, Jiang YH, Wang YR, Liu ZL, Ding PL, Wang XY, Cui WQ, Xu XQ, Wang YH
Danggui-Shaoyao-San Can Ameliorate Alzheimer's Disease by Inhibiting Hippocampal Neuron Apoptosis: Findings from Serum Pharmacology.
Drug Des Devel Ther. 2025;19:911-929. Epub 2025 Feb 10 PubMed.PAPER Jiang X, Zheng Y, Sun H, Dang Y, Yin M, Xiao M, Wu T
Fecal Microbiota Transplantation Improves Cognitive Function of a Mouse Model of Alzheimer's Disease.
CNS Neurosci Ther. 2025 Feb;31(2):e70259. PubMed.PAPER Weiss JN, Eber D
Earlier diagnosis of Alzheimer's disease by dynamic light scattering spectroscopy.
J Alzheimers Dis. 2025 Feb 16;:13872877251319352. Epub 2025 Feb 16 PubMed.PAPER Kim J, Yoon HH, Chung JH, Hong SH, Jeon SR
Neurochemical Characterization of A53T-alpha-synuclein and 6-OHDA Rat Models for Parkinson's Disease through Animal PET Imaging Analysis.
J Korean Neurosurg Soc. 2025 Feb 17; Epub 2025 Feb 17 PubMed.PAPER Shukla R, Mishra K, Singh S
Exploring therapeutic potential of Bacopa monnieri bioactive compounds against Alzheimer's and Parkinson's diseases.
3 Biotech. 2025 Mar;15(3):61. Epub 2025 Feb 14 PubMed.Current Filters
No filters selected